Related Experiment Video
Updated: Jul 19, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Cytomegalovirus induces interferon-stimulated gene expression and is attenuated by interferon in the developing brain
Anthony N van den Pol1, Michael D Robek, Prabhat K Ghosh
1Department of Neurosurgery, Yale University School of Medicine, 333 Cedar St., New Haven, CT 06520, USA. anthony.vandenpol@yale.edu
Abstract:
Cytomegalovirus (CMV) is considered the most common infectious agent causing permanent neurological dysfunction in the developing brain. We have previously shown that CMV infects developing brain cells more easily than it infects mature brain cells and that this preference is independent of the host B- and T-cell responses. In the present study, we examined the innate antiviral defenses against mouse (m) and human (h) CMVs in developing and mature brain and brain cells. mCMV infection induced interferon (IFN)-stimulated gene expression by 10- to 100-fold in both glia- and neuron-enriched cultures. Treatment of primary brain cultures with IFN-alpha, -beta, and -gamma or a synthetic RNA, poly(I:C), reduced the number of mCMV-infected cells, both in older cells and in fresh cultures from embryonic mouse brains. When a viral dose that killed almost all unprotected cells was used, IFN-protected cells had a natural appearance, and when they were tested with whole-cell patch clamp recording, they appeared physiologically normal with typical resting membrane potentials and action potentials. mCMV infection increased expression of representative IFN-stimulated genes (IFIT3, OAS, LMP2, TGTP, and USP18) in both neonatal and adult brains to similarly large degrees. The robust upregulation of gene expression in the neonatal brain was associated with a much higher degree of viral replication at this stage of development. In contrast to the case for downstream gene induction, CMV upregulated IFN-alpha/beta expression to a greater degree in the adult brain than in the neonatal brain. Similar to the case with cultured brain cells, IFN treatment of the developing brain in vivo depressed mCMV replication. In parallel work with cultured primary human brain cells, IFN and poly(I:C) treatment reduced hCMV infection and prevented virus-mediated cell death. These results suggest that coupling IFN administration with current treatments may reduce CMV infections in the developing brain.
Insights
Cytomegalovirus (CMV) infections pose a risk to the developing brain. Interferon (IFN) treatments effectively protected developing brain cells from both mouse and human CMV, suggesting a potential therapeutic strategy.
Area of Science:
- Neuroscience
- Immunology
- Virology
Background:
- Cytomegalovirus (CMV) is a leading cause of congenital neurological damage.
- Previous research indicated CMV preferentially infects developing brain cells, independent of adaptive immunity.
Purpose of the Study:
- To investigate innate antiviral defenses against mouse (m) and human (h) CMV in developing and mature brain cells.
- To evaluate the efficacy of interferon (IFN) in protecting against CMV infection in the brain.
Main Methods:
- Examined interferon-stimulated gene expression in response to mCMV infection in glial and neuronal cultures.
- Treated primary brain cultures and in vivo models with various IFNs and poly(I:C) to assess protection.
- Assessed physiological function of IFN-protected cells using patch clamp recordings.
- Investigated hCMV infection in human brain cells with IFN and poly(I:C) treatment.
Main Results:
- mCMV infection robustly induced interferon-stimulated genes in both developing and mature brain cells.
- IFN treatment significantly reduced mCMV and hCMV infection and prevented virus-induced cell death in cultured brain cells.
- IFN-protected cells maintained normal physiological function.
- IFN administration in vivo suppressed mCMV replication in the developing brain.
Conclusions:
- Innate immune responses, particularly interferon signaling, play a crucial role in controlling CMV infection in the brain.
- Interferon treatment demonstrates significant potential for reducing CMV infection and associated neurological damage in the developing brain.
- Combining IFN therapy with existing treatments may enhance protection against CMV in vulnerable populations.
Related Concept Videos
Cytomegalovirus Disease
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors Of Virion Release
Encephalitis ll: Pathophysiology

